Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients

被引：0
|
作者：
V. Nataraj
S. Rastogi
S. A. Khan
M. C. Sharma
S. Agarwala
S. Vishnubhatla
S. Bakhshi
机构：
[1] Dr. B.R.A Institute Rotary Cancer Hospital,Department of Medical Oncology
[2] All India Institute of Medical Sciences,Department of Orthopedics
[3] All India Institute of Medical Sciences,Department of Pathology
[4] All India Institute of Medical Sciences,Department of Pediatric Surgery
[5] All India Institute of Medical Sciences,Department of Biostatistics
[6] All India Institute of Medical Sciences,undefined
来源：
Clinical and Translational Oncology | 2016年 / 18卷
关键词：
Delayed metastasectomy; Metastatic osteosarcoma; Without high dose methotrexate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：937 / 944
页数：7
相关论文
共 50 条
  • [1] Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients
    Nataraj, V.
    Rastogi, S.
    Khan, S. A.
    Sharma, M. C.
    Agarwala, S.
    Vishnubhatla, S.
    Bakhshi, S.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (09): : 937 - 944
  • [2] Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients
    Nataraj, Vijayamurugan
    Batra, Atul
    Rastogi, Shishir
    Khan, Shah Alam
    Sharma, Mehar Chand
    Vishnubhatla, Sreenivas
    Bakhshi, Sameer
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 112 (06) : 662 - 668
  • [3] The Retrospective Analysis of High Dose Chemotherapy for Osteosarcoma: A Single Center Experience
    Uemura, Suguru
    Mori, Takeshi
    Takafuji, Satoru
    Nishimura, Noriyuki
    Iijima, Kazumoto
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S88 - S88
  • [4] Methotrexate (MTX) serum peak monitoring in patients with osteosarcoma treated with high-dose methotrexate chemotherapy
    Landre, Thierry
    Cras, Audrey
    El Ghessassi, Ibrahim
    Mourez, Thomas
    Martre, Helene Sauvageon
    Faure, Pierre
    PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 499 - 499
  • [5] Outcome and prognostic factors in metastatic primitive neuroectodermal tumors with uniform chemotherapy protocol: A single center experience of 150 patients
    Bakhshi, Sameer
    Biswas, Bivas
    Mohanti, B. K.
    Shukla, N. K.
    Rastogi, Shishir
    Agarwala, Sandeep
    Deo, S. V. S.
    Sharma, Dayanand
    Khan, Shah Alam
    Thulkar, Sanjay
    Vishnubhatla, Sreenivas
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] EXPERIENCE WITH PREOPERATIVE, HIGH-DOSE METHOTREXATE (HDMTX) CONTAINING CHEMOTHERAPY IN PATIENTS WITH OSTEOSARCOMA (OSA)
    HONEGGER, HP
    CSERHATI, MD
    VONHOCHSTETTER, A
    HOFMANN, V
    GROSCURTH, P
    CANCER DRUG DELIVERY, 1986, 3 (01): : 69 - 69
  • [7] Pronostic Factor of Hemogram Parameters in Patients with Osteosarcoma Treated with High Dose Methotrexate and Etoposide/Ifosfamide Chemotherapy
    Bastard, P.
    Cozic, N.
    Gaspar, N.
    Pacquement, H.
    Ikonomova, R.
    Brugieres, L.
    Cleirec, M.
    Piperno-Neumann, S.
    Rigaud, C.
    Abbas, R.
    Minard-Colin, V.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S298 - S298
  • [8] Clinical analysis of osteosarcoma patients treated with high-dose methotrexate-free neoadjuvant chemotherapy
    Xu, M.
    Xu, F.
    Yu, C.
    CURRENT ONCOLOGY, 2014, 21 (05) : E678 - E684
  • [9] Outcome and prognostic factors in localized osteosarcoma with uniform chemotherapy protocol: A single-center experience of 234 cases.
    Murugan, Vijaya
    Bakhshi, Sameer
    Rastogi, Shishir
    Khan, Shah Alam
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] High dose methotrexate containing regimen in pediatric non-metastatic extremity osteosarcoma patients: experience from a tertiary cancer center in India
    Rajeswari, Binitha
    Guruprasad, Chellapan Sojamani
    Nair, Manjusha
    Prasanth, Varikkattu Rajendran
    Sugath, Bhaskar Subin
    Thankamony, Priyakumari
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2022, 39 (03) : 225 - 232
12345